HIGHER CTX-M, TEM, AND SHV EXTENDED-SPECTRUM BETA-LACTAMASE PLASMID GENE COMBINATION FREQUENCY IN ESBL PRODUCING KLEBSIELLA PNEUMONIAE COMPARED WITH ESBL PRODUCING ESCHERICHIA COLI [PDF]
, 2016 Vita Skuja +9 more
openalex +1 more source
Carbapenemases from the Laboratory to the Clinic in Gram-Negative Enteric Bacteria [PDF]
Mediterranean Journal of Infection, Microbes and Antimicrobials, 2012 In gram-negative bacteria, antimicrobial resistance related to beta-lactamases is a serious problem in the management of healthcare- related infections.
Sinem BUDAK, Zerrin AKTAŞ, Hakan ERDEM
doaj
Peptidase activity of beta-lactamases.
The Biochemical journal, 1999 Although beta-lactamases have generally been considered as being devoid of peptidase activity, a low but significant hydrolysis of various N-acylated dipeptides was observed with representatives of each class of beta-lactamases. The kcat/Km values were below 0.1 M(-1).
Rhazi, Noureddine +3 more
openaire +2 more sources
ß-Lactam-ß-lactamase Inhibitor Combination against ESBL-Producing Enterobacteriaceae
Majallah-i Dānishgāh-i ’Ulūm-i Pizishkī-i Shahīd Ṣadūqī Yazd, 2016 In the last decades, Extended-Spectrum-β-Lactamases (ESBLs) in gram negative bacilli have appeared as a significant mechanism of resistance to antibiotics. Although resistance to carbapenems is increasing among bacteria, they are still the treatment
A Hashemi
doaj
بررسی مقاومت دارويی ناشی از بتالاکتاماز وسيع الطيف (Extended Spectrum ß Lactamases=ESBLs) در اشريشيا کلی با مقاومت چندگانه دارويی در بيماران بستری [PDF]
, 2008 زمينه و هدف: اشريشياکلی يکی از مهمترين و بيشترين باکتریهايی است که از عفونتهای کلينيکی بخصوص در بيماران بستری در بيمارستان جدا میشود، اخيراً مقاومت دارويی آن بويژه به چندين آنتیبيوتيک از دستههای دارويی مختلف مورد توجه قرار گرفته است و از آنجائی که
طواف لنگرودی, زهره +3 more
core
A functional classification scheme for beta-lactamases and its correlation with molecular structure
Antimicrobial Agents and Chemotherapy, 1995 K. Bush +2 more
semanticscholar +1 more source
Point of care tests for hospital-acquired infections (HAIs) : economic analysis report [PDF]
A number of clinical/disease areas have been prioritised by the Technology Strategy Board (TSB) and Department of Health (DH) for the DIIA Innovation Platform.
Osipenko, Leeza, Szczepura, Ala
core
beta-Lactamases in laboratory and clinical resistance
Clinical Microbiology Reviews, 1995 D. Livermore
semanticscholar +1 more source